Establishment Labs price target raised to $60 from $50 at TD Cowen

TD Cowen raised the firm’s price target on Establishment Labs to $60 from $50 and keeps an Outperform rating on the shares. The firm met with management who revealed that the company is continuing to move closer to Motiva’s FDA approval. Management expects to receive a GMP inspection date “very soon” and is also engaged in labeling discussions with the agency.